Neurocrine Biosciences, Inc. Announces Conference Call and Webcast to Provide Indiplon Update

SAN DIEGO, Dec. 12 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. announced today that the Company will host a live conference call and webcast to provide an update on indiplon Thursday morning, December 13, 2007. The call will take place at 9:00 a.m. Eastern Time (6:00 a.m. Pacific Time).

Participants can access the live conference call by dialing 1-800-895-4790, (US) or 785-424-1071 (International) using the conference ID: NEURO12. The call can also be accessed via the webcast through the Company's website at http://www.neurocrine.com

If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600. A replay of the conference call will be available approximately one hour after the conclusion of the call by dialing 1-800-695-0974 (US) or 402-220-1459 (International) using the conference ID: NEURO12. The call will be archived for two weeks.

Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. The product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, irritable bowel syndrome, endometriosis and CNS related disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com

CONTACT: Elizabeth Foster of Neurocrine Biosciences, +1-858-617-7600

Web site: http://www.neurocrine.com/